封面
市场调查报告书
商品编码
1663601

末梢栓塞防止设备的全球市场 - 市场规模(各市场区隔),占有率,法规,偿付,干预,预测(~2036年)

Peripheral Embolic Protection Devices Market Size by Segments, Share, Regulatory, Reimbursement, Interventions and Forecast to 2036

出版日期: | 出版商: GlobalData | 英文 | 订单完成后即时交付

价格

本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

本报告提供全球末梢栓塞防止设备市场相关调查分析,提供各地区市场规模,主要趋势,创新的产品与技术,竞争情形等资讯。

市场模型的主要组成如下:

上市的外周栓塞保护装置和不断发展的竞争格局

  • 主要产业趋势分析
  • 週边栓塞保护装置市场各细分市场的年收入及市场预测(2015-2036 年)
  • 有关干预总数、单位数量、平均销售价格和每个细分市场的市场价值的详细数据

全球、区域和国家层面的市场洞察

  • 按地区和全球趋势细分的定性市场讯息,并提供每个国家/地区的市场洞察
  • 週边栓塞保护装置市场的 SWOT 分析
  • 分析週边栓塞保护装置市场的竞争动态与趋势

透过获得真正的整体视角(包括医疗保健系统概述)来了解您的市场。此外,市场进入部分提供有关报销政策和监管环境的信息,从而可以更深入地了解市场动态。

  • 各国医疗保健体系概述
  • 各国的报销政策
  • 各国医疗科技监理状况

对象企业

  • Medtronic Plc
  • Abbott Laboratories
  • Boston Scientific Corp
  • Cordis Corp
  • 其他
简介目录
Product Code: GDME671MM

Peripheral Embolic Protection Devices Market Size by Segments, Share, Regulatory, Reimbursement, Interventions and Forecast to 2036 is built to visualize quantitative and qualitative market trends within Cardiovascular Devices therapeutic area.

Peripheral Embolic Protection Devices are used to capture and remove plaque debris that is dislodged during interventional process. Peripheral Embolic Protection Devices used in the lower extremity, carotid and renal arteries are included here. Various methods have been employed in attempts to reduce distal embolization events as a result of endovascular interventions. Present technologies for Embolic Protection Devices (EPD) employ three important strategies: distal occlusion, proximal occlusion and distal filtration.

Each of the covered 39 country's color-coded and fully-sourced market models are equipped with epidemiology based indications with intervention volumes. The interactive excel deliverable covers installed base, new sales volumes, product usage, average selling prices, market size and company share/rank analysis (wherever available). Moreover, analyst comments with qualitative insight offer context for quantitative data.

Key Inclusions of the market model are -

Currently marketed Peripheral Embolic Protection Devices market and evolving competitive landscape -

  • Insightful review of the key industry trends.
  • Annualized total Peripheral Embolic Protection Devices market revenue by segment and market outlooks from 2015-2036.
  • Granular data on total interventions, units, average selling prices and market values by segment.

Global, Regional and Country level market specific insights -

  • Qualitative market specific information is available with global trends further broken down into regional trends. In addition GlobalData analysts provide unique country specific insights on the market.
  • SWOT analysis for Peripheral Embolic Protection Devices market.
  • Competitive dynamics insights and trends provided Peripheral Embolic Protection Devices market.

Drive the understanding of the market by getting the veritable big picture including an overview of the healthcare system. In addition the Market Access segment allows you to delve deeper into market dynamics with information on reimbursement policies and the regulatory landscape.

  • Country specific overview of the healthcare system.
  • Country specific reimbursement policies.
  • Country specific medtech regulatory landscape.

Robust methodologies and sources enable the model to provide extensive and accurate overview of the market. Demand and supply-side primary sources are integrated within the syndicated models, including Key Opinion Leaders. In addition, real world data sources are leveraged to determine market trends; these include government procedure databases, hospital purchasing databases, and proprietary online databases.

Companies covered: Medtronic Plc, Abbott Laboratories, Boston Scientific Corp, Cordis Corp, and Others.

Countries covered: United States, United Kingdom, Germany, France, Italy, Spain, Brazil, China, India, Russia, Japan, Australia, Canada, Mexico, South Korea, Denmark, Ireland, Netherlands, New Zealand, South Africa, Sweden, Switzerland, Austria, Belgium, Finland, Israel, Norway, Poland, Portugal, Taiwan, Czech Republic, Greece, Hungary, Turkey, Egypt, Saudi Arabia, United Arab Emirates, Argentina and Chile.

Scope

This Market Model gives important, expert insight you won't find in any other source. The model illustrates qualitative and quantitative trends within the specified market. This model is required reading for -

  • CMO executives who must have deep understanding of the Peripheral Embolic Protection Devices marketplace to make strategic planning and investment decisions.
  • Sourcing and procurement executives who must understand crucial components of the supply base in order to make decisions about supplier selection and management.
  • Private equity investors that need a deeper understanding of the market to identify and value potential investment targets.

Reasons to Buy

The model will enable you to -

  • Develop and design your in-licensing and out-licensing strategies through a review of pipeline products, by identifying key companies.
  • Develop business strategies by understanding the trends shaping and driving Peripheral Embolic Protection Devices market.
  • Drive revenues by understanding the key trends, innovative products and technologies, market segments, and companies likely to impact the Peripheral Embolic Protection Devices market in the future.
  • Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the company share of market leaders.
  • Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage.
  • Track device sales in the global and country-specific Peripheral Embolic Protection Devices market from 2015-2036.
  • Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments and strategic partnerships.